Results 191 to 200 of about 117,898 (292)

Long-term outcomes of patients with Chronic Myeloid Leukemia who commenced treatment with imatinib: a 20-year single-centre experience

, 2022
Elżbieta Szczepanek, Ositadima Chukwu, Magdalena Kamińska, Hubert Wysogląd, Agnieszka Cenda, Magdalena Zawada, Małgorzata Jakóbczyk, Joanna Wącław, Tomasz Sacha   +8 more
openalex   +2 more sources

Molecular Characterization of a Complex <i>PDGFRB</i> Structural Variation in Infantile Myofibroma With Complete Response to Imatinib. [PDF]

JCO Precis Oncol
Bastianelli WE, Wu J, Ahsan MU, Szepessy AM, Schubert J, Balamuth NJ, Chan J, Denenberg EH, Luo M, Pollock AN, Russo PA, Rybacki K, Xu F, Zhong Y, Surrey LF, Wang K, Laetsch TW, Li MM.   +17 more
europepmc   +1 more source

Imatinib (Gleevec®) as a Paradigm of Targeted Cancer Therapies

, 2010
Brian Druker
openalex   +2 more sources

Ulcers and Eosinophils: A Rare Presentation of PDGFRA-Rearranged Myeloid Neoplasm Responding to Imatinib. [PDF]

J Investig Med High Impact Case Rep
Calderon A, Goyal S, Loayza Pintado J, Cantazaro B, Cobos E.   +4 more
europepmc   +1 more source

O tratamento da Leucemia Mielóide Crônica com mesilato de imatinibe Therapy of Chronic Myeloid Leukemia with imatinib mesylate

, 2008
Vaneuza M. Funke, D.C. Setubal, Jefferson Ruiz, Ana Paula de Azambuja, Denise H. Lima, Terezinha K. Kojo, Ricardo Pasqüini   +6 more
openalex   +1 more source

The potential effects of green tea (-)-epigallocatechin-3-gallate on overcoming imatinib-resistance in chronic myeloid leukemia bearing BCR-ABL

, 2019
Bùi Thị Kim Lý, Hoàng Thanh
openalex   +2 more sources

Targeting Musashi-2 to counteract senescence and resistance in chronic myeloid leukemia: enhancing the efficacy of imatinib therapy. [PDF]

BMC Cancer
Arif K, Yousaf M, Khan D.
europepmc   +1 more source

A cohort study of molecular response to Imatinib in patients with chronic-phase chronic myeloid leukemia in Azerbaijan [PDF]

A. Hasanova, Chingiz Asadov, Aytan Shirinova, Gunay Aliyeva, Zohra Alimirzoyeva   +4 more
openalex   +1 more source

Adaphostin-induced oxidative stress overcomes BCR/ABL mutation-dependent and -independent imatinib resistance [PDF]

, 2005
Joya Chandra
openalex   +1 more source

Association of fibronectin 1 deregulation with tyrosine kinase inhibitor resistance in chronic myeloid leukemia. [PDF]

Front Cell Dev Biol
Tiedemann L, Gorantla SP, Ahlf P, Schmidt LS, Pott C, Litterst M, Waetzig V, Nagel I, Ruemenapp J, von Bubnoff N, Cascorbi I, Kaehler M.   +11 more
europepmc   +1 more source